Potency Assurance for Cellular and Gene Therapy Products
Detailed guidance document from FDA and regulatory agencies.
Document Details
Guidance Document
December 27, 2023
December 28, 2023
2a9b0d81-9dd5-43cf-994c-ac0df102c216
Related Documents
Recommendations to Reduce the Risk of Transfusion-Transmitted Malaria: Draft Guidance for Industry
Guidance DocumentJanuary 15, 2025Center for Biologics Evaluation and Research
Frequently Asked Questions — Developing Potential Cellular and Gene Therapy Products
Guidance DocumentNovember 18, 2024Center for Biologics Evaluation and Research
Manufacturing Changes and Comparability for Human Cellular and Gene Therapy Products
Guidance DocumentJuly 13, 2023Center for Biologics Evaluation and Research
Quick Actions
Transform Regulatory Data into Actionable Intelligence
Join leading pharmaceutical and medical device companies who trust GKS for their regulatory compliance needs.
Try KeyPedia Today
Explore our real use cases and discover our features in depth.
Stay ahead of FDA enforcement
New KeyPedia insights, webinars, and regulatory analysis — straight to your inbox. Unsubscribe anytime.